Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pal Riba

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Neurochemistry|January 11, 2007
Serotonin and epilepsyGyorgy Bagdy, Valeria Kecskemeti, Pal Riba, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 26, 2001
Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptorsPal Riba, Yong Ben, Andrew P Smith, et al.
Brain Research Bulletin|September 12, 2007
DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferensMahmoud Al-Khrasani, Mariana Spetea, Tamas Friedmann, et al.
Current Pharmaceutical Design|March 2, 2013
Functionalization of the carbonyl group in position 6 of morphinan-6-ones. Development of novel 6-amino and 6-guanidino substituted 14-alkoxymorphinansHelmut Schmidhammer, Mariana Spetea, Petra Windisch, et al.
European Journal of Pharmacology|January 20, 2004
In vitro opioid activity profiles of 6-amino acid substituted derivatives of 14-O-methyloxymorphoneMariana Spetea, Tamas Friedmann, Pal Riba, et al.
Current Medicinal Chemistry|February 28, 2002
[Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphinePal Riba, Yong Ben, Thi M-D Nguyen, et al.
Pharmacology, Biochemistry, and Behavior|March 3, 2010
Does the effect of morphine challenge change on maternal behaviour of dams chronically treated with morphine during gestation and further on during lactation?Melinda Sobor, Julia Timár, Pal Riba, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 24, 2004
Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the ratSusanna Fürst, Pal Riba, Tamas Friedmann, et al.
Journal of Medicinal Chemistry|January 18, 2011
Synthesis and pharmacological activities of 6-glycine substituted 14-phenylpropoxymorphinans, a novel class of opioids with high opioid receptor affinities and antinociceptive potenciesMariana Spetea, Petra Windisch, Yan Guo, et al.
Brain Research Bulletin|August 4, 2015
A new potent analgesic agent with reduced liability to produce morphine toleranceKornel Kiraly, Francesca Felicia Caputi, Adrienn Hanuska, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Neurochemistry|January 11, 2007
Serotonin and epilepsyGyorgy Bagdy, Valeria Kecskemeti, Pal Riba, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 26, 2001
Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptorsPal Riba, Yong Ben, Andrew P Smith, et al.
Brain Research Bulletin|September 12, 2007
DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferensMahmoud Al-Khrasani, Mariana Spetea, Tamas Friedmann, et al.
Current Pharmaceutical Design|March 2, 2013
Functionalization of the carbonyl group in position 6 of morphinan-6-ones. Development of novel 6-amino and 6-guanidino substituted 14-alkoxymorphinansHelmut Schmidhammer, Mariana Spetea, Petra Windisch, et al.
European Journal of Pharmacology|January 20, 2004
In vitro opioid activity profiles of 6-amino acid substituted derivatives of 14-O-methyloxymorphoneMariana Spetea, Tamas Friedmann, Pal Riba, et al.
Current Medicinal Chemistry|February 28, 2002
[Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphinePal Riba, Yong Ben, Thi M-D Nguyen, et al.
Pharmacology, Biochemistry, and Behavior|March 3, 2010
Does the effect of morphine challenge change on maternal behaviour of dams chronically treated with morphine during gestation and further on during lactation?Melinda Sobor, Julia Timár, Pal Riba, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 24, 2004
Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the ratSusanna Fürst, Pal Riba, Tamas Friedmann, et al.
Journal of Medicinal Chemistry|January 18, 2011
Synthesis and pharmacological activities of 6-glycine substituted 14-phenylpropoxymorphinans, a novel class of opioids with high opioid receptor affinities and antinociceptive potenciesMariana Spetea, Petra Windisch, Yan Guo, et al.
Brain Research Bulletin|August 4, 2015
A new potent analgesic agent with reduced liability to produce morphine toleranceKornel Kiraly, Francesca Felicia Caputi, Adrienn Hanuska, et al.
Pageof 1